SuperworthAbeona Therapeutics market cap ABEO
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $251.6M
- Highest close in our data
- $987M
- Apr 2018
Abeona Therapeutics is worth $251.6M at the close on Oct 23, 2026, at $4.40 a share.
That is down 10% over the last year and up 207% over five years.
Its highest close in our data was $987M in Apr 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $251.6M | $244.7M | $412.6M | −15% |
| 2025 | $295.3M | $215.4M | $370.7M | +21% |
| 2024 | $244.7M | $89.2M | $288.9M | +97% |
| 2023 | $124.1M | $38.6M | $124.1M | +135% |
| 2022 | $52.9M | $18M | $69.4M | +53% |
| 2021 | $34.7M | $29.6M | $291.6M | −78% |
| 2020 | $154.7M | $87.3M | $277M | −12% |
| 2019 | $174.9M | $75.9M | $390.8M | −48% |
| 2018 | $336.6M | $313.6M | $987M | −55% |
| 2017 | $741.4M | $189.2M | $783.5M | +283% |
| 2016 | $193.8M | $76.9M | $289.7M | +76% |
| 2015 | $110M | $1.6M | $212.6M | +5531% |
| 2014 | $2M | $2M | $15.1M | −71% |
| 2013 | $6.6M | $6M | $14.5M | +10% |
| 2012 | $6M | $5.6M | $33.4M | −82% |
| 2011 | $33.4M | $15.3M | $33.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Abeona Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| ABEOAbeona Therapeutics | $251.6M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Abeona Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.